Relay Technology Management, a Boston, Massachusetts-based software analytics company focused on the life sciences industry, has received a strategic investment of undisclosed amount from Nature Publishing Group.
Led by David Greenwald, Ph.D. Managing Director and Co-founder, Relay is building a software platform designed to provide next generation predictive analytics to the transactional licensing markets in the biotechnology and pharmaceutical industry.
The company is currently recruiting beta testers for product, which will launch in early 2012.
Commenting on the investment, Peter Collins, Business Intelligence Director, Nature Publishing Group, said: “We are…confident that Relay’s innovative approach and strong entrepreneurial spirit will complement SciBX: Science Business eXchange, Nature Medicine, Nature Biotechnology, Nature Reviews Drug Discovery, and our other products in this area”.
Part of Macmillan Publishers Limited, Nature Publishing Group globally publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine. The company has principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Cairo, Delhi, Mumbai, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC.